• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

_video 辅助胸腔镜肺叶切除术治疗 IA 期肺腺癌复发和转移的预测列线图。

Nomogram for predicting recurrence and metastasis of stage IA lung adenocarcinoma treated by videoassisted thoracoscopic lobectomy.

机构信息

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, China; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Science, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, China; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Science, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.

出版信息

Asian J Surg. 2022 Dec;45(12):2691-2699. doi: 10.1016/j.asjsur.2022.01.010. Epub 2022 Feb 10.

DOI:10.1016/j.asjsur.2022.01.010
PMID:35153141
Abstract

OBJECTIVE

This study aimed to construct a nomogram to effectively predict recurrence and metastasis in patients with stage 1A lung adenocarcinoma after video-assisted thoracoscopic surgery (VATS) lobectomy.

METHODS

Our study included 337 patients. The 3-year recurrence-free survival rate and the 5-year recurrence-free survival (5-RFS) rate were analyzed. Multivariate Cox proportional hazards regression was conducted to identify independent risk factors. We established a nomogram and performed Harrell's Concordance index, calibration plots, integrated discrimination improvement, and decision curve analyses to assess its discrimination and calibration.

RESULTS

The median follow-up time was 45 months. In a multivariate analysis, tumor diameter, pathological subtype, preoperative carcinoembryonic antigen level, and preoperative CYFRA21-1 level were independent prognostic factors for RFS (P < 0.05). These risk factors were used to construct a nomogram to predict postoperative recurrence and metastasis in these patients. Internal verification was performed using the bootstrap method. The C-index was 0.946 (95% confidence interval: 0.923-0.970), indicating that the model had a good predictive performance. Using the nomogram and X-tile software, the patients were divided into two groups: the high-risk (5-RFS rate, 0.10-0.90) and low-risk groups (5-RFS rate, 0.90-0.99); the difference in the RFS rate between the groups was significant (χ2 = 86.705, P < 0.001).

CONCLUSIONS

Our nomogram had a better predictive ability for recurrence and metastasis in patients with stage 1A lung adenocarcinoma after VATS lobectomy resection than the Tumor-Node-Metastasis staging system and other predictive models. This nomogram can help provide individualized treatment strategies and follow-up times.

摘要

目的

本研究旨在构建一个列线图,以有效预测接受电视辅助胸腔镜手术(VATS)肺叶切除术后 1A 期肺腺癌患者的复发和转移。

方法

本研究纳入了 337 例患者。分析了 3 年无复发生存率和 5 年无复发生存率(5-RFS)。采用多变量 Cox 比例风险回归分析确定独立的危险因素。我们建立了一个列线图,并进行了 Harrell 的一致性指数、校准图、综合判别改善和决策曲线分析,以评估其判别和校准能力。

结果

中位随访时间为 45 个月。多变量分析显示,肿瘤直径、病理亚型、术前癌胚抗原水平和术前细胞角蛋白 19 片段 21-1 水平是 RFS 的独立预后因素(P<0.05)。这些危险因素被用于构建一个列线图,以预测这些患者术后的复发和转移。内部验证采用 bootstrap 方法。C 指数为 0.946(95%置信区间:0.923-0.970),表明该模型具有良好的预测性能。使用列线图和 X-tile 软件,将患者分为两组:高风险组(5-RFS 率为 0.10-0.90)和低风险组(5-RFS 率为 0.90-0.99);两组间 RFS 率差异有统计学意义(χ2=86.705,P<0.001)。

结论

与肿瘤-淋巴结-转移分期系统和其他预测模型相比,我们的列线图对 VATS 肺叶切除术后 1A 期肺腺癌患者的复发和转移具有更好的预测能力。该列线图有助于提供个体化的治疗策略和随访时间。

相似文献

1
Nomogram for predicting recurrence and metastasis of stage IA lung adenocarcinoma treated by videoassisted thoracoscopic lobectomy._video 辅助胸腔镜肺叶切除术治疗 IA 期肺腺癌复发和转移的预测列线图。
Asian J Surg. 2022 Dec;45(12):2691-2699. doi: 10.1016/j.asjsur.2022.01.010. Epub 2022 Feb 10.
2
Nomograms for predicting recurrence and survival of invasive pathological stage IA non-small cell lung cancer treated by video assisted thoracoscopic surgery lobectomy.预测接受电视辅助胸腔镜手术肺叶切除术治疗的侵袭性病理I A期非小细胞肺癌复发和生存的列线图。
J Thorac Dis. 2017 Apr;9(4):1046-1053. doi: 10.21037/jtd.2017.03.130.
3
Nomogram for the preoperative prediction of Ki-67 expression and prognosis in stage IA lung adenocarcinoma based on clinical and multi-slice spiral computed tomography features.基于临床和多层螺旋计算机断层扫描特征的IA期肺腺癌Ki-67表达及预后术前预测列线图
BMC Med Imaging. 2024 Jun 12;24(1):143. doi: 10.1186/s12880-024-01305-5.
4
Development and validation of a nomogram based on preoperative variables for predicting recurrence-free survival in stage IA lung adenocarcinoma.基于术前变量的列线图模型的建立及其在 IA 期肺腺癌无复发生存预测中的验证。
Thorac Cancer. 2023 Nov;14(31):3108-3118. doi: 10.1111/1759-7714.15099. Epub 2023 Oct 4.
5
Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study.预测IA3期肺腺癌术后无复发生存率的列线图模型的建立与验证:一项回顾性队列研究
Transl Lung Cancer Res. 2022 Nov;11(11):2275-2288. doi: 10.21037/tlcr-22-776.
6
A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.基于IA期浸润性肺腺癌微乳头和实性成分新分类的预后列线图。
J Surg Oncol. 2022 Mar;125(4):796-808. doi: 10.1002/jso.26760. Epub 2021 Dec 3.
7
Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors.基于凝血相关因素的列线图:用于早期肺腺癌患者预后评估。
Eur J Cardiothorac Surg. 2023 Nov 1;64(5). doi: 10.1093/ejcts/ezad313.
8
Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.肺癌根治术后 IA 和 IB 期患者总生存和无复发生存的预测列线图
Clin Lung Cancer. 2021 Jul;22(4):e574-e583. doi: 10.1016/j.cllc.2020.10.009. Epub 2020 Oct 22.
9
Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.Ⅰ期完全肺叶切除术后肺腺癌的辅助化疗候选者。
Ann Surg Oncol. 2019 Aug;26(8):2392-2400. doi: 10.1245/s10434-019-07366-z. Epub 2019 Apr 22.
10
Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma.临床ⅠA 期肺腺癌淋巴结转移术中预测的列线图。
Cancer Med. 2023 Jul;12(13):14360-14374. doi: 10.1002/cam4.6115. Epub 2023 May 22.

引用本文的文献

1
Survival analysis and clinicopathological features of patients with stage IA lung adenocarcinoma.IA期肺腺癌患者的生存分析及临床病理特征
Heliyon. 2023 Dec 6;10(1):e23205. doi: 10.1016/j.heliyon.2023.e23205. eCollection 2024 Jan 15.
2
Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study.基于人群的研究:估算 IA 期肺腺癌的治愈率。
BMC Pulm Med. 2023 Oct 31;23(1):417. doi: 10.1186/s12890-023-02725-9.
3
A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung Adenocarcinoma.
基于实变肿瘤比率联合实性或微乳头模式的列线图预测病理ⅠA期肺腺癌术后复发情况
Diagnostics (Basel). 2023 Jul 14;13(14):2376. doi: 10.3390/diagnostics13142376.